CircGDI2 Regulates the Proliferation, Migration, Invasion and Apoptosis of OSCC via miR-454-3p/FOXF2 Axis

References

• Thomson PJ. Perspectives on oral squamous cell carcinoma prevention-proliferation, position, progression and prediction. J Oral Pathol Med. 2018;47(9):803–807. doi:10.1111/jop.1273329752860
   PubMed Web of Science ®Google Scholar
• Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5):309–316. doi:10.1016/j.oraloncology.2008.06.00218804401
   PubMed Web of Science ®Google Scholar
• Jiang S, Dong Y. Human papillomavirus and oral squamous cell carcinoma: A review of HPV-positive oral squamous cell carcinoma and possible strategies for future. Curr Probl Cancer. 2017;41(5):323–327. doi:10.1016/j.currproblcancer.2017.02.00628416242
   PubMed Web of Science ®Google Scholar
• Patop IL, Wust S, Kadener S. Past, present, and future of circRNAs. EMBO J. 2019;38(16):e100836. doi:10.15252/embj.201810083631343080
   PubMed Web of Science ®Google Scholar
• Shang Q, Yang Z, Jia R, Ge S. The novel roles of circRNAs in human cancer. Mol Cancer. 2019;18(1):6. doi:10.1186/s12943-018-0934-630626395
   PubMed Web of Science ®Google Scholar
• Momen-Heravi F, Bala S. Emerging role of non-coding RNA in oral cancer. Cell Signal. 2018;42:134–143. doi:10.1016/j.cellsig.2017.10.00929056500
   PubMed Web of Science ®Google Scholar
• Li B, Wang F, Li X, et al. Hsa_circ_0008309 may be a potential biomarker for oral squamous cell carcinoma. Dis Markers. 2018;2018:7496890. doi:10.1155/2018/749689030344795
   PubMed Web of Science ®Google Scholar
• Gao L, Zhao C, Li S, et al. circ-PKD2 inhibits carcinogenesis via the miR-204-3p/APC2 axis in oral squamous cell carcinoma. Mol Carcinog. 2019;58(10):1783–1794. doi:10.1002/mc.2306531206208
   PubMed Web of Science ®Google Scholar
• Su W, Wang Y, Wang F, et al. Hsa_circ_0005379 regulates malignant behavior of oral squamous cell carcinoma through the EGFR pathway. BMC Cancer. 2019;19(1):400. doi:10.1186/s12885-019-5593-531035951
   PubMed Web of Science ®Google Scholar
• Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234(5):5451–5465. doi:10.1002/jcp.2748630471116
   PubMed Web of Science ®Google Scholar
• Bertoli G, Cava C, Castiglioni I. MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics. 2015;5(10):1122–1143. doi:10.7150/thno.1154326199650
   PubMed Web of Science ®Google Scholar
• Sharma N, Baruah MM. The microRNA signatures: aberrantly expressed miRNAs in prostate cancer. Clin Transl Oncol. 2019;21(2):126–144. doi:10.1007/s12094-018-1910-829951892
   PubMed Web of Science ®Google Scholar
• Chitkara D, Mittal A, Mahato RI. miRNAs in pancreatic cancer: therapeutic potential, delivery challenges and strategies. Adv Drug Deliv Rev. 2015;81:34–52. doi:10.1016/j.addr.2014.09.00625252098
   PubMed Web of Science ®Google Scholar
• Zuo J, Yu H, Xie P, et al. miR-454-3p exerts tumor-suppressive functions by down-regulation of NFATc2 in glioblastoma. Gene. 2019;710:233–239. doi:10.1016/j.gene.2019.06.00831181312
   PubMed Web of Science ®Google Scholar
• Song Y, Guo Q, Gao S, Hua K. miR-454-3p promotes proliferation and induces apoptosis in human cervical cancer cells by targeting TRIM3. Biochem Biophys Res Commun. 2019;516(3):872–879. doi:10.1016/j.bbrc.2019.06.12631270028
   PubMed Web of Science ®Google Scholar
• Guo JY, Wang YK, Lv B, Jin H. miR-454 performs tumor-promoting effects in oral squamous cell carcinoma via reducing NR3C2. J Oral Pathol Med 2020;49(4):286–293. doi:10.1111/jop.13015
   Google Scholar
• He W, Kang Y, Zhu W, et al. FOXF2 acts as a crucial molecule in tumours and embryonic development. Cell Death Dis. 2020;11(6):424. doi:10.1038/s41419-020-2604-z32503970
   PubMed Web of Science ®Google Scholar
• Wang H, Ma N, Li W, Wang Z. MicroRNA-96-5p promotes proliferation, invasion and EMT of oral carcinoma cells by directly targeting FOXF2. Biol Open. 2020;9(3):bio049478. doi:10.1242/bio.04947832014885
   PubMed Web of Science ®Google Scholar
• Gharat SA, Momin M, Bhavsar C. Oral squamous cell carcinoma: current treatment strategies and nanotechnology-based approaches for prevention and therapy. Crit Rev Ther Drug Carrier Syst. 2016;33(4):363–400. doi:10.1615/CritRevTherDrugCarrierSyst.201601627227910740
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang S, Wu J, et al. circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family. Oncogene. 2017;36(32):4551–4561. doi:10.1038/onc.2017.8928368401
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tang K, Chen L, et al. Exosomal circGDI2 suppresses oral squamous cell carcinoma progression through the regulation of miR-424-5p/SCAI Axis. Cancer Manag Res. 2020;12:7501–7514. doi:10.2147/CMAR.S25568732943917
   PubMed Web of Science ®Google Scholar
• Babaei K, Shams S, Keymoradzadeh A, et al. An insight of microRNAs performance in carcinogenesis and tumorigenesis; an overview of cancer therapy. Life Sci. 2020;240:117077. doi:10.1016/j.lfs.2019.11707731751586
   PubMed Web of Science ®Google Scholar
• Harrandah AM, Mora RA, Chan EKL. Emerging microRNAs in cancer diagnosis, progression, and immune surveillance. Cancer Lett. 2018;438:126–132. doi:10.1016/j.canlet.2018.09.01930237038
   PubMed Web of Science ®Google Scholar
• Aali M, Mesgarzadeh AH, Najjary S, et al. Evaluating the role of microRNAs alterations in oral squamous cell carcinoma. Gene. 2020;757:144936. doi:10.1016/j.gene.2020.14493632640301
   PubMed Web of Science ®Google Scholar
• Wang F, Ye LJ, Wang FJ, Liu HF, Wang XL. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells. Environ Toxicol. 2020;35(10):1050–1057. doi:10.1002/tox.2294132469461
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang Z, Huang W, Zeng J. MiR-4282 inhibits tumor progression through down-regulation of ZBTB2 by targeting LIN28B in oral squamous cell carcinoma. J Cell Physiol. 2020. doi:10.1002/jcp.29458
   Web of Science ®Google Scholar
• Li Y, Jiao Y, Fu Z, et al. High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma. Cancer Manag Res. 2019;11:2795–2802. doi:10.2147/CMAR.S19665531114333
   PubMed Web of Science ®Google Scholar
• Guo JY, Wang YK, Lv B, Jin H. miR-454 performs tumor-promoting effects in oral squamous cell carcinoma via reducing NR3C2. J Oral Pathol Med. 2020;49(4):286–293. doi:10.1111/jop.1301532170966
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang C, Sang L, et al. FOXF2 inhibits proliferation, migration, and invasion of Hela cells by regulating Wnt signaling pathway. Biosci Rep. 2018;38(5). doi:10.1042/BSR20180747
   Web of Science ®Google Scholar
• Shi Z, Liu J, Yu X, et al. Loss of FOXF2 expression predicts poor prognosis in hepatocellular carcinoma patients. Ann Surg Oncol. 2016;23(1):211–217. doi:10.1245/s10434-015-4515-225824262
   PubMed Web of Science ®Google Scholar
• Ni WJ, Leng XM. miRNA-dependent activation of mRNA translation. MicroRNA. 2016;5(2):83–86. doi:10.2174/221153660566616082515120127568791
   PubMedGoogle Scholar